Skip to main navigation Skip to search Skip to main content

SBIR Phase II: Enhancing Performance and Achieving Commercial Readiness for the PQS1.0 Rapid Phenylalanine Blood Level Monitor

Project: Research

Abstract & Details

Description

Award ID: 2332518

This Small Business Innovation Research (SBIR) Phase II project addresses a pressing need for a rapid and user-friendly method to monitor blood phenylalanine levels in individuals with phenylketonuria (PKU), a lifelong genetic disorder impairing phenylalanine processing, an amino acid found in many common foods. Left untreated or poorly managed, PKU can result in intellectual disabilities, behavioral issues, and severe health complications. In the U.S., an estimated 20,000 to 35,000 individuals grapple with PKU, demanding consistent blood phenylalanine level monitoring as part of their disease management. The annual costs of PKU care can vary from $15,000 to $200,000 per individual, with higher costs linked to inadequate management, leading to irreversible damage and substantial healthcare services. Currently, monitoring occurs with intervals of 3 to 5 days or even up to two weeks, constrained by factors like test sites, facility availability, and turnaround times. Ideally, PKU monitoring should align with individual needs, occurring daily in sync with diet, age, health factors, and gestational period. Enhanced monitoring frequency is widely recognized as beneficial, and this project aims to improve PKU care by providing accessible and frequent monitoring for improved patient outcomes. This Small Business Innovation Research (SBIR) Phase II project aims to develop a rapid phenylalanine monitor for phenylketonuria (PKU) patients. The project offers rapid analysis of blood phenylalanine levels to enhance patient outcomes and improve the current standard of care. Consisting of a test strip and a test device, the system accepts a blood drop from a finger prick. The test strip conditions the blood sample with specific analytes before the test device analyzes the sample. The project's core focus is optimizing product design and system algorithms, enabling cost-effective manufacturing and deployment for end-users. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Henry Ahn
StatusActive
Effective start/end date05/01/2404/30/27

Funding

  • SBIR Phase II: $997,142.00

Active Fiscal Year

  • FY2024
  • FY2027
  • FY2026
  • FY2025

Start Fiscal Year

  • FY2024

TIP Programs

  • SBIR Phase II

Small Business

  • Yes

Key Technology Areas

  • Biotechnology
  • (confidence score: 100%)

Technology Foci

  • Synthetic Biology
  • (confidence score: 99%)
  • Genomics and bioinformatics
  • (confidence score: 100%)

Congressional District at Award

  • District n. 40 of California

Current Congressional District

  • District n. 40 of California

United States

  • California

Core Based Statistical Area (CBSA)

  • Los Angeles-Long Beach-Anaheim, CA

County

  • County: Orange, CA

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine